Pricing Log in Create free account

ProKidney Corp. (PROK) vs Prothena Corporation plc (PRTA)

ProKidney Corp. and Prothena Corporation plc are both Biotechnology companies. ProKidney Corp. and Prothena Corporation plc are of similar size ($439.9M and $436.4M). Prothena Corporation plc has the higher net margin (−80.7% vs −10,288.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Prothena Corporation plc leads on 10 and ProKidney Corp. on 2.

Valuation

Metric PROK PRTA Biotechnology median
P/E n/m n/m 8.50
P/S 303.33 7.98 9.71
P/B n/m 1.52 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 81.78 2.70 9.21
Earnings yield (41.35%) (9.94%) (33.15%)
Free cash flow yield (57.04%) (13.96%) (25.50%)

Profitability

Metric PROK PRTA Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (21,664.55%) (101.80%) 0.00%
Net margin (10,288.39%) (80.67%) 0.00%
Free cash flow margin (17,300.61%) (111.49%) 0.00%
Return on equity 8.92% (14.39%) (56.36%)
Return on assets (27.10%) (12.54%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PROK PRTA Biotechnology median
Revenue growth (TTM) — 427.32% 6.02%
EPS growth (last fiscal year) 16.13% (99.56%) 30.26%
Revenue growth, 5-year CAGR — 62.56% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PROK PRTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.36 25.05 4.72
Net debt to EBITDA 1.70 1.46 0.96

Dividend

Metric PROK PRTA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PROK PRTA Biotechnology median
Market cap 439.88m 436.36m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack